The legislation prohibits the retail sale of synthetic drugs, and creates a prevention initiative.(Published Jan 21, 2014)
The new rules require municipal advisors to register with the SEC, and mandate a new level of disclosure.(Published Sep 30, 2013)
Moody’s is also proposing new criteria and is accepting comments now.